Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Conmed (CNMD) Short-Term Debt issuances (2016 - 2026)

Conmed filings provide 13 years of Short-Term Debt issuances readings, the most recent being $180.0 million for Q1 2026.

  • On a quarterly basis, Short-Term Debt issuances rose 8.43% to $180.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $709.4 million, a 7.0% increase, with the full-year FY2025 number at $695.4 million, down 7.4% from a year prior.
  • Short-Term Debt issuances hit $180.0 million in Q1 2026 for Conmed, down from $187.0 million in the prior quarter.
  • In the past five years, Short-Term Debt issuances ranged from a high of $254.0 million in Q1 2024 to a low of $62.0 million in Q2 2022.
  • Median Short-Term Debt issuances over the past 5 years was $167.0 million (2025), compared with a mean of $163.4 million.
  • Biggest five-year swings in Short-Term Debt issuances: soared 154.84% in 2023 and later plummeted 34.65% in 2025.
  • Conmed's Short-Term Debt issuances stood at $143.0 million in 2022, then grew by 25.87% to $180.0 million in 2023, then decreased by 16.67% to $150.0 million in 2024, then increased by 24.67% to $187.0 million in 2025, then dropped by 3.74% to $180.0 million in 2026.
  • The last three reported values for Short-Term Debt issuances were $180.0 million (Q1 2026), $187.0 million (Q4 2025), and $167.0 million (Q3 2025) per Business Quant data.